1. Home
  2. OIM vs SPRY Comparison

OIM vs SPRY Comparison

Compare OIM & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneIM Acquisition Corp. Class A Ordinary Shares

OIM

OneIM Acquisition Corp. Class A Ordinary Shares

SELL

Current Price

$10.11

Market Cap

364.0M

Sector

N/A

ML Signal

SELL

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$2.95

Market Cap

400.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OIM
SPRY
Founded
2025
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.0M
400.8M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
OIM
SPRY
Price
$10.11
$2.95
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
164.7K
★ 2.3M
Earning Date
N/A
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $84,278,000.00
Revenue This Year
N/A
$43.93
Revenue Next Year
N/A
$42.53
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.96
$2.44
52 Week High
$10.33
$13.15

Technical Indicators

Market Signals
Indicator
OIM
SPRY
Relative Strength Index (RSI) 48.57 37.07
Support Level $10.06 $2.44
Resistance Level $10.16 $4.44
Average True Range (ATR) 0.01 0.41
MACD -0.00 0.02
Stochastic Oscillator 33.33 31.36

Price Performance

Historical Comparison
OIM
SPRY

About OIM OneIM Acquisition Corp. Class A Ordinary Shares

OneIM Acquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: